Computational analyses for cancer biology based on exhaustive experimental backgrounds
暂无分享,去创建一个
[1] P. Schumacker,et al. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.
[2] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[3] R. Reddel,et al. Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.
[4] David Lane,et al. p53 Research: the past thirty years and the next thirty years. , 2010, Cold Spring Harbor perspectives in biology.
[5] S. Weinhouse,et al. The Warburg hypothesis fifty years later , 2004, Zeitschrift für Krebsforschung und Klinische Onkologie.
[6] J. Little,et al. Folate, DNA stability and colo-rectal neoplasia , 2004, Proceedings of the Nutrition Society.
[7] J. Dick,et al. Stem cell concepts renew cancer research. , 2008, Blood.
[8] S. Vokes,et al. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice , 2012, Proceedings of the National Academy of Sciences.
[9] Stephen L. Abrams,et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. , 2007, Biochimica et biophysica acta.
[10] H. Ishii,et al. Depletion of JARID1B induces cellular senescence in human colorectal cancer. , 2013, International journal of oncology.
[11] M. Blasco. Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.
[12] H. Matsui,et al. Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer. , 2015, International journal of oncology.
[13] K. Schulze-Osthoff,et al. Cancer stem cell markers in common cancers - therapeutic implications. , 2008, Trends in molecular medicine.
[14] Hua-Chuan Zheng. The molecular mechanisms of chemoresistance in cancers , 2017, Oncotarget.
[15] D. Bar-Sagi,et al. RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.
[16] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[17] H. Ishii,et al. Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity. , 2014, International journal of oncology.
[18] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[19] H. Matsui,et al. Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells , 2018, Scientific Reports.
[20] K. Macleod. The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer? , 2010, The Journal of clinical investigation.
[21] S. Ravanel,et al. One-Carbon Metabolism in Plants. Regulation of Tetrahydrofolate Synthesis during Germination and Seedling Development , 2003, Plant Physiology.
[22] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[23] J. Shay,et al. Hayflick, his limit, and cellular ageing , 2000, Nature Reviews Molecular Cell Biology.
[24] John L Cleveland,et al. Myc pathways provoking cell suicide and cancer , 2003, Oncogene.
[25] A. Chou,et al. Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer , 2014, PloS one.
[26] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[27] P. M. Campbell,et al. Oncogenic Ras and its role in tumor cell invasion and metastasis. , 2004, Seminars in cancer biology.
[28] H. Matsui,et al. A Trans-omics Mathematical Analysis Reveals Novel Functions of the Ornithine Metabolic Pathway in Cancer Stem Cells , 2016, Scientific Reports.
[29] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[30] W. R. Bruce,et al. A Quantitative Assay for the Number of Murine Lymphoma Cells capable of Proliferation in vivo , 1963, Nature.
[31] L. Jaenicke. VITAMIN AND COENZYME FUNCTION: VITAMIN B 12 AND FOLIC ACID. , 1964, Annual review of biochemistry.
[32] G. Qing,et al. Targeting oncogenic Myc as a strategy for cancer treatment , 2018, Signal Transduction and Targeted Therapy.
[33] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[34] H. Ishii,et al. Polyamine flux suppresses histone lysine demethylases and enhances ID1 expression in cancer stem cells , 2018, Cell Death Discovery.
[35] P. Leedman,et al. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. , 2002, The Biochemical journal.
[36] A. Lusis,et al. Considerations for the design of omics studies , 2017 .
[37] Ita Novita Sari,et al. Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment , 2018, Stem cells international.
[38] David A. Williams,et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.
[39] Akane Kawamura,et al. Recent Progress in Histone Demethylase Inhibitors. , 2016, Journal of medicinal chemistry.
[40] H. Kim,et al. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development , 2018, Theranostics.
[41] H. Lodish,et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.
[42] D. Root,et al. Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival. , 2018, Cancer discovery.
[43] H. Ishii,et al. Visualization and characterization of cancer stem-like cells in cervical cancer. , 2014, International journal of oncology.
[44] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[45] P. Stover,et al. Trafficking of intracellular folates. , 2011, Advances in nutrition.
[46] Robert A. Weinberg,et al. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.
[47] H. Ishii,et al. Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2 , 2018, Heliyon.
[48] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[49] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[50] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[51] Gang Li,et al. Cancer chemoresistance: The relationship between p53 and multidrug transporters , 2002, International journal of cancer.
[52] E. Adams. Amino acid metabolism. , 1962, Annual review of biochemistry.
[53] Hiroyuki Kubota,et al. Trans-Omics: How To Reconstruct Biochemical Networks Across Multiple 'Omic' Layers. , 2016, Trends in biotechnology.
[54] Z. Hall. Cancer , 1906, The Hospital.
[55] A. Inga,et al. More targets, more pathways and more clues for mutant p53 , 2013, Oncogenesis.
[56] T. Oberley. Oxidative damage and cancer. , 2002, The American journal of pathology.
[57] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[58] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[59] R. Mackenzie,et al. Mitochondrial one-carbon metabolism is adapted to the specific needs of yeast, plants and mammals. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[60] Jean C. Y. Wang. Good cells gone bad: the cellular origins of cancer. , 2010, Trends in molecular medicine.
[61] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[62] Igor Jurisica,et al. Cancer computational biology , 2011, BMC Bioinformatics.
[63] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[64] E. Racker. Why do tumor cells have a high aerobic glycolysis? , 1976, Journal of cellular physiology.
[65] Niko Beerenwinkel,et al. Computational Cancer Biology: An Evolutionary Perspective , 2016, PLoS Comput. Biol..
[66] E. Asselin,et al. Chemoresistance and targeted therapies in ovarian and endometrial cancers , 2016, Oncotarget.
[67] A. Fernández-Medarde,et al. Ras in cancer and developmental diseases. , 2011, Genes & cancer.
[68] M. Birnbaum,et al. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. , 1987, Science.
[69] S. Inoue,et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. , 2015, Cancer cell.
[70] H. Ishii,et al. Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth , 2013, Molecular and clinical oncology.
[71] B. Vogelstein,et al. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.
[72] C. Ryu,et al. Cancer stem cell surface markers on normal stem cells , 2017, BMB reports.
[73] R. Kuick,et al. Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer , 2016, Cell.
[74] L. Reitzer,et al. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.
[75] J. Sayre,et al. In vivo imaging, tracking, and targeting of cancer stem cells. , 2009, Journal of the National Cancer Institute.
[76] Varda Rotter,et al. Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. , 2011, Genes & cancer.
[77] Serban Nacu,et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.
[78] H. Shimizu,et al. Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer , 2016, Scientific Reports.
[79] J. Shay,et al. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies , 2016, Genome Medicine.
[80] David E. Muench,et al. c-Myc and Cancer Metabolism , 2012, Clinical Cancer Research.
[81] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[82] T. Ochiya,et al. Drug Resistance Driven by Cancer Stem Cells and Their Niche , 2017, International journal of molecular sciences.
[83] I. Weissman,et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.
[84] A. Levine,et al. The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.
[85] B. Vogelstein,et al. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention , 2017, Science.